Mamedica

Last updated

Mamedica is a London, UK-based medical cannabis clinic which was founded in 2021 and launched in 2022.[ citation needed ] It is one of four UK clinics licensed to prescribe and dispense medical cannabis.[ citation needed ]

Contents

History

In August 2022, it published a survey of 4,000 people which found that 60% of British people would consider using cannabis to treat medical conditions, particularly if prescribed by a doctor. [1] [2] A February 2023 survey for Mamedica found a third of respondents would use medical marijuana to help treat depression. [3]

In June 2023, Mamedica announced a strategic UK partnership with Canadian medical cannabis products supplier 4C Labs. [4]

The clinic has reported a 400% increase in patients since it was founded. [5] Robson says the clinic aims "to offer an alternative to conventional medicines to individuals who are struggling with a severe medical condition and desire to regain a sense of normalcy in their daily lives". [6]

Mamedica is a member of the UK's Cannabis Industry Council. [7]

Patient conditions

Since June 2022, 40% of Mamedica's prescriptions have been for mental health conditions, including anxiety, depression, stress, insomnia and post-traumatic stress disorder. [8] In 2023, Mamedica reported an increase in demand from patients suffering from psychiatric conditions and opting to use medical cannabis as a replacement for traditional medication that can cause side effects. [9]

In addition, the clinic prescribes CBD to support patients with menopause symptoms like hot flushes, [10] and the clinic supports patients living with chronic neurological pain, with bespoke cannabis-based prescription medicines (CBPMs) that improve individuals' overall quality of life by reducing symptoms of depression and anxiety. [11]

Eligibility for treatment

While more than 89,000 private medical cannabis prescriptions have been made in the UK, there have been fewer than five medical cannabis prescriptions via the NHS. [12] UK legislation states that a prescription for medical cannabis can only be initiated by a specialist consultant on the General Medical Council (GMC) register. [13] Before patients can book a Mamedica consultation, they need to have tried at least two licensed medications or treatments and must not have any history of schizophrenia or psychosis. [14] Patients must provide their medical records and details about their family medical history to mitigate any potential risks of using CBPMs. [14]

Treatment

Mamedica doctors can prescribe CBPMs including THC, Cannabidiol (CBD) and balanced cannabis profiles and cannabis flower, oil, capsules and cartridges for patients living with chronic conditions. [15] Mamedica's cannabis flower prescriptions are strictly for use in dry-herb vaporisers, devices that let patients heat the flower and inhale its contents as a vapour. [14]

See also

Related Research Articles

<span class="mw-page-title-main">Insomnia</span> Disorder causing trouble with sleeping

Insomnia, also known as sleeplessness, is a sleep disorder where people have trouble sleeping. They may have difficulty falling asleep, or staying asleep for as long as desired. Insomnia is typically followed by daytime sleepiness, low energy, irritability, and a depressed mood. It may result in an increased risk of accidents of all kinds as well as problems focusing and learning. Insomnia can be short term, lasting for days or weeks, or long term, lasting more than a month. The concept of the word insomnia has two possibilities: insomnia disorder (ID) and insomnia symptoms, and many abstracts of randomized controlled trials and systematic reviews often underreport on which of these two possibilities the word insomnia refers to.

<span class="mw-page-title-main">Medical cannabis</span> Marijuana used medicinally

Medical cannabis, or medical marijuana (MMJ), is cannabis and cannabinoids that are prescribed by physicians for their patients. The use of cannabis as medicine has not been rigorously tested due to production and governmental restrictions, resulting in limited clinical research to define the safety and efficacy of using cannabis to treat diseases.

<span class="mw-page-title-main">Medical prescription</span> Health-care communication from a physician to a pharmacist

A prescription, often abbreviated ℞ or Rx, is a formal communication from a physician or other registered healthcare professional to a pharmacist, authorizing them to dispense a specific prescription drug for a specific patient. Historically, it was a physician's instruction to an apothecary listing the materials to be compounded into a treatment—the symbol ℞ comes from the first word of a medieval prescription, Latin recipere, that gave the list of the materials to be compounded.

Self-medication, sometime called do-it-yourself (DIY) medicine, is a human behavior in which an individual uses a substance or any exogenous influence to self-administer treatment for physical or psychological conditions, for example headaches or fatigue.

<span class="mw-page-title-main">Depression (mood)</span> State of low mood and aversion to activity

Depression is a mental state of low mood and aversion to activity. It affects more than 280 million people of all ages. Depression affects a person's thoughts, behavior, feelings, and sense of well-being. Depressed people often experience loss of motivation or interest in, or reduced pleasure or joy from, experiences that would normally bring them pleasure or joy.

<span class="mw-page-title-main">Dextropropoxyphene</span> Withdrawn opioid medication

Dextropropoxyphene is an analgesic in the opioid category, patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive and local anaesthetic effects. The drug has been taken off the market in Europe and the US due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia is said to be 20–30 minutes and peak effects are seen about 1.5–2.0 hours after oral administration.

<span class="mw-page-title-main">Cannabidiol</span> Phytocannabinoid discovered in 1940

Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. As of 2022, clinical research on CBD included studies related to the treatment of anxiety, addiction, psychosis, movement disorders, and pain, but there is insufficient high-quality evidence that cannabidiol is effective for these conditions. CBD is also sold as a herbal dietary supplement promoted with unproven claims of particular therapeutic effects.

<span class="mw-page-title-main">Nabiximols</span> Specific cannabis extract

Nabiximols is a specific Cannabis extract that was approved in 2010 as a botanical drug in the United Kingdom. Nabiximols is sold as a mouth spray intended to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms of multiple sclerosis; it was developed by the UK company GW Pharmaceuticals. In 2019, it was proposed that following application of the spray, nabiximols is washed away from the oral mucosa by the saliva flow and ingested into the stomach, with subsequent absorption from the gastro-intestinal tract. Nabiximols is a combination drug standardized in composition, formulation, and dose. Its principal active components are the cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD). Each spray delivers a dose of 2.7 mg THC and 2.5 mg CBD.

Charges for prescriptions for medicines and some medical appliances are payable by adults in England under the age of 60. However, people may be exempt from charges in various exemption categories. Charges were abolished by NHS Wales in 2007, Health and Social Care in Northern Ireland in 2010 and by NHS Scotland in 2011. In 2010/11, in England, £450 million was raised through these charges, some 0.5% of the total NHS budget. In April 2021 the charge was raised to £9.35 for up to a three-month supply of each item. In 2022, for the first time since 2010, the charge was not increased.

Prescription cascade is the process whereby the side effects of drugs are misdiagnosed as symptoms of another problem, resulting in further prescriptions and further side effects and unanticipated drug interactions, which itself may lead to further symptoms and further misdiagnoses. This is a pharmacological example of a feedback loop. Such cascades can be reversed through deprescribing.

Electronic prescription is the computer-based electronic generation, transmission, and filling of a medical prescription, taking the place of paper and faxed prescriptions. E-prescribing allows a physician, physician assistant, pharmacist, or nurse practitioner to use digital prescription software to electronically transmit a new prescription or renewal authorization to a community or mail-order pharmacy. It outlines the ability to send error-free, accurate, and understandable prescriptions electronically from the healthcare provider to the pharmacy. E-prescribing is meant to reduce the risks associated with traditional prescription script writing. It is also one of the major reasons for the push for electronic medical records. By sharing medical prescription information, e-prescribing seeks to connect the patient's team of healthcare providers to facilitate knowledgeable decision making.

<span class="mw-page-title-main">Cannabis in the United Kingdom</span> Use of cannabis in the United Kingdom

Cannabis in the United Kingdom is illegal for recreational use and is classified as a Class B drug. In 2004, the United Kingdom made cannabis a Class C drug with less severe penalties, but it was moved back to Class B in 2009. Medical use of cannabis, when prescribed by a registered specialist doctor, was legalised in November 2018.

<span class="mw-page-title-main">Cannabis in Switzerland</span> Use of cannabis in Switzerland

Cannabis in Switzerland is illegal, though minor possession was decriminalised to a fine in 2012. Several cantons began to allow adults to cultivate and use cannabis in 2012, but this was struck down by federal courts. In 2016, four cities stated they were looking into establishing pilot cannabis clubs. The number of cannabis users in Switzerland is estimated to be around 500,000 among a population of 8 million.

<span class="mw-page-title-main">Lister Hospital, Chelsea</span> Private hospital in London

The Lister Hospital in Chelsea is a private hospital in Chelsea Bridge Road, London. It is owned by the Hospital Corporation of America, the largest private operator of health care facilities in the world, and so is not part of the National Health Service.

<span class="mw-page-title-main">Medical cannabis in the United States</span> Use of cannabis for medical purposes in the United States

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

Autophobia, also called monophobia, isolophobia, or eremophobia, is the specific phobia or a morbid fear or dread of oneself or of being alone, isolated, abandoned, and ignored. This specific phobia is associated with the idea of being alone, often causing severe anxiety.

HealthUnlocked is a social networking service for health. The company uses health-specific artificial intelligence to support patients to better manage their own health, by recommending relevant and tailored health content, information and services to patients The site enables peer support for various health conditions and promotes patient empowerment by actively engaging people with their healthcare.

<span class="mw-page-title-main">Cannabis in Thailand</span> Use of cannabis in Thailand

In Thailand, cannabis, known by the name Ganja has recently had new laws passed through. Cannabis that has less than 0.2% THC, referred to as industrial hemp in USA, was legalised on 9 June 2022. Medicinal cannabis, with no THC restrictions, was made legal in 2018 but required patients to obtain a prescription from a medical practitioner. Recreational cannabis is still illegal according to Thai law.

Medical cannabis research includes any medical research on using cannabis. Different countries conduct and respond to medical cannabis research in different ways.

Releaf is a Nottingham, UK-based medical cannabis online clinic, licensed to prescribe and dispense medical cannabis.

References

  1. ↑ Waugh, Rob (15 August 2022). "Most British people would now consider using medical cannabis, survey shows". Yahoo News. Retrieved 11 August 2023.
  2. ↑ Roberts, Joe (4 August 2023). "More than half of Brits unaware they can access cannabis on prescription". Cannabis Health News. Retrieved 11 August 2023.
  3. ↑ Maule, Will (26 February 2023). "Third of Brits would opt for medical cannabis to treat mental health conditions". Wales Online. Retrieved 11 August 2023.
  4. ↑ "Mamedica & 4C LABS Ltd. Conclude Strategic Agreement For The UK Market". Business of Cannabis. 7 June 2023. Retrieved 11 August 2023.
  5. ↑ Koronka, Poppy (August 10, 2023). "Epileptic children face losing access to medicinal cannabis" – via www.thetimes.co.uk.
  6. ↑ "UK cannabis clinic delivers weed straight to your door". LADbible. April 21, 2023.
  7. ↑ "Members". Cannabis Industry Council. Retrieved 29 February 2024.
  8. ↑ Eccles, Louise (August 10, 2023). "I used to buy cannabis from street dealers for my anxiety. Now I get a prescription" – via www.thetimes.co.uk.
  9. ↑ "ADHD sufferers are self-medicating with cannabis because of NHS delays, charity warns". Sky News.
  10. ↑ Hughes, Lauren (March 16, 2023). "Hot flushes? These patches have been hailed a 'lifesaver' for menopause symptoms". Metro.
  11. ↑ Sharp, Christopher (May 20, 2023). "'Medical cannabis changed my life,' says woman with rare neurological disorder". Express.co.uk.
  12. ↑ Shehadi, Sebastian (April 17, 2023). "England to become the second largest medical cannabis market in Europe". Investment Monitor.
  13. ↑ "Why neurodivergent people are self-medicating with weed". Dazed. July 10, 2023.
  14. 1 2 3 Hockaday, James (August 6, 2022). "Medical weed prescribed to 17,000 in UK - but many are still using black market". Metro.
  15. ↑ "Man shows how easy it can be to get a medical cannabis prescription in the UK". LADbible. April 26, 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.